Healthspan Capital

About The Fund

Healthspan Capital is a venture capital firm based in California, USA, specializing in investing in early-stage longevity biotech ('LongBio') and regenerative medicine startups with the goal of extending a healthy human lifespan. Their investment activity is focused on rejuvenation as a medicinal future, supporting a new therapeutic approach that treats aging as a disease. They have identified aging as a new therapeutic target and aim to shift the paradigm on aging, disease, and human lifespan by fostering a wave of biotech startups that bring innovative solutions to these areas.They offer a diversified investment strategy, creating a portfolio that includes a range of approaches and modalities within the longevity biotech space. Healthspan Capital is known for their deep expertise, with over a decade of experience in longevity biotech investments and company creation, as well as a vast network of collaborators, advisors, and founders in the field. Notable team members include General Partners Nathan Cheng, Sebastian Brunemeier, and Michael Chinen, who bring a combination of scientific knowledge and industry experience to the firm.Healthspan Capital operates a rolling fund on AngelList, providing a simple and accessible way for investors to contribute to the longevity biotech sector. Their investment parameters include a minimum investment of $250,000, a maximum of $750,000, and a sweet spot of $500,000. The firm's specialties are pre-seed and seed investments, with a particular interest in Latin American markets.For investors interested in the expanding field of biotech and the pursuit of solutions to increase human healthspan, Healthspan Capital presents a unique opportunity to engage with promising startups at the cutting edge of LongBio, underscored by their mission-driven philosophy where science meets mission.